Full Thickness Macular Hole Formation in a Patient with Cystoid Macular Edema Caused by CRVO Treated with Intravitreal Bevacizicumab.

Recent studies have shown the beneficial effect of intravitreal injections of Bevacizicumab in several ocular neovasular disorders, however, the possible adverse effects of this treatment have not been fully described. The authors report the development of a full thickness macular hole (FTMH) in a 44-year-old patient with cystoid macular edema secondary to central retinal vein occlusion after treatment with intravitreal injection of Bevacizicumab and describe its course after vitrectomy, internal limiting membrane peeling and gas tamponade. Copyright 2010, SLACK Incorporated.